Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 424210
Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 424210 Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages a ... Read More
-
Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 446000
Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 446000 Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.): Ana ... Read More
-
McKesson Corporation (MCK:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for McKesson Corporation (MCK:NYS) compared to its top competitors and compared to th ... Read More
-
AmerisourceBergen Corporation (ABC:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AmerisourceBergen Corporation (ABC:NYS) compared to its top competitors ... Read More
-
ARS Pharmaceuticals Inc (SPRY:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
ARS Pharmaceuticals Inc (SPRY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for ARS Pharmaceuticals Inc (SPRY:NAS) compared to its top competitors and compar ... Read More
-
Royalty Pharma PLC (RPRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Royalty Pharma PLC (RPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Royalty Pharma PLC (RPRX:NAS) compared to its top competitors and compared to the ... Read More
-
Vertex Inc (VERX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Vertex Inc (VERX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Vertex Inc (VERX:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Salem Media Group Inc (SALM:OTC): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Salem Media Group Inc (SALM:OTC): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Salem Media Group Inc (SALM:OTC) compared to its top competitors and compared t ... Read More
-
Cumberland Pharmaceuticals Inc (CPIX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Cumberland Pharmaceuticals Inc (CPIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Cumberland Pharmaceuticals Inc (CPIX:NAS) compared to its top competit ... Read More
-
Intercept Pharmaceuticals Inc (ICPT:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Intercept Pharmaceuticals Inc (ICPT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Intercept Pharmaceuticals Inc (ICPT:NAS) compared to its top competitor ... Read More
-
Ironwood Pharmaceuticals Inc (IRWD:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ironwood Pharmaceuticals Inc (IRWD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ironwood Pharmaceuticals Inc (IRWD:NAS) compared to its top competitors ... Read More
-
AEterna Zentaris Inc (AEZS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AEterna Zentaris Inc (AEZS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AEterna Zentaris Inc (AEZS:NAS) compared to its top competitors and compared to ... Read More
-
AbbVie Inc (ABBV:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
AbbVie Inc (ABBV:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for AbbVie Inc (ABBV:NYS) compared to its top competitors and compared to the average for all ... Read More
-
Inovio Pharmaceuticals Inc (INO:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Inovio Pharmaceuticals Inc (INO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Inovio Pharmaceuticals Inc (INO:NAS) compared to its top competitors and co ... Read More
-
Ionis Pharmaceuticals Inc (IONS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ionis Pharmaceuticals Inc (IONS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ionis Pharmaceuticals Inc (IONS:NAS) compared to its top competitors and co ... Read More
-
Merck and Co Inc (MRK:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Merck and Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Merck and Co Inc (MRK:NYS) compared to its top competitors and compared to the averag ... Read More
-
Karyopharm Therapeutics Inc (KPTI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Karyopharm Therapeutics Inc (KPTI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Karyopharm Therapeutics Inc (KPTI:NAS) compared to its top competitors an ... Read More
-
Abbott Laboratories (ABT:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Abbott Laboratories (ABT:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Abbott Laboratories (ABT:NYS) compared to its top competitors and compared to the ... Read More
-
Incyte Corporation (INCY:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Incyte Corporation (INCY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Incyte Corporation (INCY:NAS) compared to its top competitors and compared to the ... Read More
-
Recursion Pharmaceuticals Inc (RXRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Recursion Pharmaceuticals Inc (RXRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Recursion Pharmaceuticals Inc (RXRX:NAS) compared to its top competitor ... Read More
-
Spectrum Pharmaceuticals Inc (SPPI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Spectrum Pharmaceuticals Inc (SPPI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Spectrum Pharmaceuticals Inc (SPPI:NAS) compared to its top competitors ... Read More
-
BioCryst Pharmaceuticals Inc (BCRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
BioCryst Pharmaceuticals Inc (BCRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for BioCryst Pharmaceuticals Inc (BCRX:NAS) compared to its top competitors ... Read More
-
Arrowhead Pharmaceuticals Inc (ARWR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Arrowhead Pharmaceuticals Inc (ARWR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Arrowhead Pharmaceuticals Inc (ARWR:NAS) compared to its top competitor ... Read More
-
Ultragenyx Pharmaceutical Inc (RARE:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ultragenyx Pharmaceutical Inc (RARE:NAS) compared to its top competitor ... Read More
-
Reata Pharmaceuticals (RETA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Reata Pharmaceuticals (RETA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Reata Pharmaceuticals (RETA:NAS) compared to its top competitors and compared t ... Read More
Research Assistance
